On the other hand, PD-1-ICB does not act on the tumor cells but they rather rescue the antitumor activity of tumor infiltrating cytotoxic T cells (CTLs) mostly attenuated as consequence of PD-1 binding to PD-L1/2 in the tumor (1, 5, 6). This evidence concerns the gene CD274 and neoplasm.